Alkyl Amines Chemicals Limited announced the approval for the grant of 28,300 stock options to eligible employees under the ‘AACL Employees Stock Option Plan 2018’ on March 31, 2026. These options are convertible into equity shares with exercise prices set at Rs.1,125/- and Rs.875/- per share. The options have a vesting period spanning 1 to 4 years, and the exercise window post-vesting is 5 years.
Approval of Employee Stock Option Grant
The Nomination and Remuneration Committee of the Board of Directors of Alkyl Amines Chemicals Limited convened on Tuesday, March 31, 2026, and approved the grant of stock options under the existing “AACL Employees Stock Option Plan 2018”. This action confirms the allocation of new equity benefits to eligible employees of the Company.
Key Details of the Grant
The total number of stock options granted in this round is 28,300. Each option entitles the holder to one equity share with a face value of Rs.2/- each. The Committee confirmed that the scheme adheres to the applicable Securities and Exchange Board of India regulations.
Pricing and Exercise Structure
The grant involves two distinct exercise price tiers:
- 21,900 stock options are priced at an exercise price of Rs.1,125/- per option/per share.
- 6,400 stock options are priced at an exercise price of Rs.875/- per option/per share.
Vesting and Exercise Schedule
The planned timeline for the utilization of these options is structured as follows:
The stock options granted will vest over a period ranging from 1 year to 4 years from the grant date. Subsequently, employees will have a window of 5 years from the date of vesting within which the options may be exercised.
Source: BSE
